SS Innovations International Inc.
SS Innovations International, Inc., together with its subsidiaries, designs, develops, manufactures, and markets surgical robotic systems in India and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI " Automated Coronary Anastomotic Connector, a micro staplin… Read more
SS Innovations International Inc. (SSII) - Net Assets
Latest net assets as of September 2024: $13.89 Million USD
Based on the latest financial reports, SS Innovations International Inc. (SSII) has net assets worth $13.89 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($37.81 Million) and total liabilities ($23.92 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $13.89 Million |
| % of Total Assets | 36.74% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SS Innovations International Inc. - Net Assets Trend (2019–2023)
This chart illustrates how SS Innovations International Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SS Innovations International Inc. (2019–2023)
The table below shows the annual net assets of SS Innovations International Inc. from 2019 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $14.30 Million | +681.09% |
| 2022-12-31 | $-2.46 Million | -1841.04% |
| 2021-12-31 | $141.33K | +116.26% |
| 2020-12-31 | $-869.05K | +18.27% |
| 2019-12-31 | $-1.06 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to SS Innovations International Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2946018000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $17.07K | 0.12% |
| Other Comprehensive Income | $570.82K | 3.99% |
| Other Components | $49.04 Million | 342.98% |
| Total Equity | $14.30 Million | 100.00% |
SS Innovations International Inc. Competitors by Market Cap
The table below lists competitors of SS Innovations International Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Suzhou Huazhijie Telecom Co
SHG:603400
|
$251.09 Million |
|
CIVMEC LTD CDI 1:1
F:1CV0
|
$251.09 Million |
|
Dodla Dairy Limited
NSE:DODLA
|
$251.14 Million |
|
Corsair Gaming Inc
NASDAQ:CRSR
|
$251.19 Million |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
$250.98 Million |
|
Yunnan Tourism Co Ltd
SHE:002059
|
$250.95 Million |
|
SK Discovery Co Ltd
KO:006125
|
$250.89 Million |
|
Jamna Auto Industries Limited
NSE:JAMNAAUTO
|
$250.73 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SS Innovations International Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -2,460,547 to 14,297,984, a change of 16,758,531.
- Net loss of 20,941,972 reduced equity.
- New share issuances of 808,244 increased equity.
- Other comprehensive income decreased equity by 344,621.
- Other factors increased equity by 37,236,880.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-20.94 Million | -146.47% |
| Share Issuances | $808.24K | +5.65% |
| Other Comprehensive Income | $-344.62K | -2.41% |
| Other Changes | $37.24 Million | +260.43% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares SS Innovations International Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 81.75x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-0.05 | $9.10 | x |
| 2020-12-31 | $-0.37 | $9.10 | x |
| 2021-12-31 | $0.05 | $9.10 | x |
| 2022-12-31 | $-0.06 | $9.10 | x |
| 2023-12-31 | $0.11 | $9.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SS Innovations International Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -146.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -356.17%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 1.78x
- Recent ROE (-146.47%) is above the historical average (-239.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.87 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.04 Million |
| 2021 | -1050.28% | 0.00% | 0.00x | 3.03x | $-1.50 Million |
| 2022 | 0.00% | -384.11% | 0.17x | 0.00x | $-5.36 Million |
| 2023 | -146.47% | -356.17% | 0.23x | 1.78x | $-22.37 Million |
Industry Comparison
This section compares SS Innovations International Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SS Innovations International Inc. (SSII) | $13.89 Million | 0.00% | 1.72x | $250.99 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |